河北(bei)天(tian)成藥(yao)業(ye)(ye)(ye)(ye)(ye)股(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)始(shi)建(jian)于1970年(nian)(nian),1998年(nian)(nian)由國(guo)(guo)有(you)(you)企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)改(gai)制(zhi)(zhi)為有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si),是(shi)滄(cang)州(zhou)市十家改(gai)制(zhi)(zhi)企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)之一,也是(shi)一家虧損(sun)企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)改(gai)制(zhi)(zhi)成功的企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)。2010年(nian)(nian)3月改(gai)制(zhi)(zhi)為股(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si),河北(bei)天(tian)成藥(yao)業(ye)(ye)(ye)(ye)(ye)股(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)除母公(gong)(gong)(gong)司(si)(si)以外還下設兩(liang)個公(gong)(gong)(gong)司(si)(si),即(ji):“河北(bei)道恩藥(yao)業(ye)(ye)(ye)(ye)(ye)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)”,“河北(bei)天(tian)成藥(yao)業(ye)(ye)(ye)(ye)(ye)股(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)滄(cang)州(zhou)渤海分公(gong)(gong)(gong)司(si)(si)(河北(bei)諾(nuo)特藥(yao)業(ye)(ye)(ye)(ye)(ye)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si))”,已形成藥(yao)物研發、原(yuan)料藥(yao)、制(zhi)(zhi)劑全(quan)產(chan)業(ye)(ye)(ye)(ye)(ye)鏈,原(yuan)料藥(yao)企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)坐落(luo)在(zai)臨港經(jing)濟開發區(qu),制(zhi)(zhi)劑企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)坐落(luo)在(zai)滄(cang)州(zhou)市經(jing)濟開發區(qu),是(shi)滄(cang)州(zhou)市大型的綜(zong)合性制(zhi)(zhi)藥(yao)企(qi)(qi)業(ye)(ye)(ye)(ye)(ye)。公(gong)(gong)(gong)司(si)(si)產(chan)品(pin)暢(chang)銷全(quan)國(guo)(guo)31個省市及地(di)區(qu),部分產(chan)品(pin)遠銷到(dao)東(dong)歐、東(dong)南亞(ya)、中亞(ya)、南美(mei)洲和非(fei)洲等30多個地(di)區(qu)和國(guo)(guo)家。
目(mu)前,公(gong)(gong)(gong)司現有職工1000多(duo)(duo)人(ren)、擁有碩士(shi)研究生(sheng)以上學歷人(ren)員60余人(ren),大(da)學生(sheng)350余人(ren),中(zhong)高(gao)級專業職稱者230人(ren),專職質(zhi)檢人(ren)員120人(ren)。公(gong)(gong)(gong)司在高(gao)速發(fa)(fa)展(zhan)(zhan)(zhan)的(de)(de)同時,一直大(da)力(li)發(fa)(fa)展(zhan)(zhan)(zhan)新(xin)(xin)(xin)(xin)產(chan)品(pin)研發(fa)(fa)工作(zuo)。目(mu)前已經(jing)成功(gong)投產(chan)的(de)(de)新(xin)(xin)(xin)(xin)藥(yao)產(chan)品(pin)和國內仿(fang)制藥(yao)產(chan)品(pin)有:平衡鹽沖洗液、木糖醇氯化鈉注(zhu)(zhu)射(she)(she)液(新(xin)(xin)(xin)(xin)藥(yao))、α-酮酸(suan)片、阿魏酸(suan)鈉、注(zhu)(zhu)射(she)(she)用(yong)轉化糖、注(zhu)(zhu)射(she)(she)用(yong)磷(lin)酸(suan)肌(ji)酸(suan)鈉、復方電解質(zhi)注(zhu)(zhu)射(she)(she)液等。目(mu)前,公(gong)(gong)(gong)司已經(jing)開(kai)發(fa)(fa)了新(xin)(xin)(xin)(xin)藥(yao)品(pin)種3個,仿(fang)制新(xin)(xin)(xin)(xin)藥(yao)20多(duo)(duo)個,落戶(hu)產(chan)品(pin)16個。2019年(nian)(nian),我公(gong)(gong)(gong)司實現銷售收入近10億元,全(quan)年(nian)(nian)研發(fa)(fa)投入近3600萬(wan)元。目(mu)前,公(gong)(gong)(gong)司積(ji)極主(zhu)動(dong)地謀求以脂質(zhi)體抗(kang)癌、心腦(nao)血管(guan)、腫瘤、免疫調節(jie)等代謝類疾病用(yong)藥(yao)為(wei)開(kai)發(fa)(fa)的(de)(de)方向,發(fa)(fa)展(zhan)(zhan)(zhan)多(duo)(duo)劑(ji)型并存(cun),大(da)力(li)發(fa)(fa)展(zhan)(zhan)(zhan)無(wu)菌水針(zhen)劑(ji)及無(wu)菌滴眼液。同時結合水針(zhen)劑(ji)重點產(chan)品(pin)開(kai)發(fa)(fa)原料藥(yao),實現從(cong)原料到制劑(ji)的(de)(de)產(chan)業鏈配套生(sheng)產(chan),建(jian)立起品(pin)種、技術(shu)與品(pin)牌優(you)(you)勢。努(nu)力(li)提高(gao)現有產(chan)品(pin)的(de)(de)技術(shu)水平,降低成本,同時以現有生(sheng)產(chan)設施(shi)為(wei)依托,以市(shi)場需求為(wei)導(dao)向,積(ji)極尋求具有比較(jiao)優(you)(you)勢的(de)(de)新(xin)(xin)(xin)(xin)產(chan)品(pin)。
公(gong)司生(sheng)產大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)劑、小(xiao)容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)劑、粉針劑、片劑、顆(ke)粒劑、膠囊(nang)劑等六(liu)個劑型近(jin)200種產品和中(zhong)藥提(ti)取物。我公(gong)司以大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)劑和小(xiao)容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)劑為(wei)主,做專業的(de)注(zhu)(zhu)(zhu)(zhu)射(she)劑藥品生(sheng)產商。大容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)液產品齊全(quan),多種包(bao)裝形(xing)式并存,在PP瓶(ping)(ping)、軟袋(dai)、玻璃瓶(ping)(ping)輸(shu)(shu)液的(de)基礎(chu)上(shang),向(xiang)雙室(shi)袋(dai)、多室(shi)袋(dai)等國(guo)際(ji)先進的(de)輸(shu)(shu)液包(bao)裝形(xing)式發展。小(xiao)容(rong)(rong)(rong)量(liang)(liang)注(zhu)(zhu)(zhu)(zhu)射(she)劑在玻璃安瓿的(de)基礎(chu)上(shang),大力發展塑(su)瓶(ping)(ping)(PP和PE)安瓿及西林瓶(ping)(ping)小(xiao)水(shui)針劑。積極謀求(qiu)國(guo)際(ji)高(gao)端GMP認證,由內(nei)銷(xiao)為(wei)主向(xiang)內(nei)銷(xiao)與出口并重轉(zhuan)變。